Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2026-08-18 20:29:50 ET · period of report 2026-08-14 · accession 0001780088-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 20:29 | 2026-08-14 | STOK | Ticho Barry | Chief MEDICAL Off | M - OptEx | $0.00 | +10.0K | 30.4K | +49% | $0 |
| DM | 2026-08-18 20:29 | 2026-08-18 | STOK | Ticho Barry | Chief MEDICAL Off | S - Sale+OE | $32.03 | -4,767 | 25.7K | -16% | -$152.7K |
| D | 2026-08-18 20:29 | 2026-08-14 | STOK | Ticho Barry | Chief MEDICAL Off | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | M | A | 10,000 | $0.00 | 30,422 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-18 | S | D | 4,525 | $32.01 | 25,897 | D | — | — | (F1) The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. |
| 3 | Common | Common Stock | 2026-08-18 | S | D | 242 | $32.47 | 25,655 | D | — | — | (F1) The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive. |
| 4 | Derivative | Performance Stock Units | 2026-08-14 | M | D | 10,000 | $0.00 | 0 | D | — · — to 2026-08-14 | 10,000 Common Stock | (F4) Each performance stock unit represents a right to receive one share of the Issuer's common stock. (F5) Achievement of this performance stock unit award was certified on August 14, 2025. Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date. |